Zebra Capital Management’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-3,762
Closed -$202K 166
2021
Q1
$202K Sell
3,762
-21,267
-85% -$1.22M 0.22% 151
2020
Q4
$1.23M Buy
25,029
+2,310
+10% +$107K 1.55% 5
2020
Q3
$738K Buy
+22,719
New +$722K 1.14% 15
2018
Q2
Sell
-10,184
Closed -$57K 362
2018
Q1
$57K Buy
+10,184
New +$63K 0.02% 332

Other funds holding VCYT

Zebra Capital Management's VCYT Position: Q2 2021 in Review

Zebra Capital Management sold out of Veracyte (VCYT) in Q2 2021, closing a stake of 3,762 shares — an estimated $202K sold.

Zebra Capital Management first reported a position in VCYT in Q1 2018 and held it in 4 quarters. The position peaked at $1.23M in Q4 2020. 214 funds tracked by Wall St. Rank hold VCYT as of Q2 2021.

  • Zebra Capital Management reported no remaining Veracyte position as of Q2 2021 after selling out during the quarter.
  • Zebra Capital Management sold 3,762 Veracyte shares in Q2 2021, an estimated $202K.
  • Zebra Capital Management first reported a position in Veracyte in Q1 2018 and held it in 4 quarters.
  • Zebra Capital Management's Veracyte position peaked at $1.23M in Q4 2020.
  • 214 funds tracked by Wall St. Rank held Veracyte as of Q2 2021.

Based on Zebra Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.